Arcutis Biotherapeutics Inc (ARQT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
14.62 -0.19 (-1.28%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 14.65 +0.03 (+0.21%) 17:30 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 36,085 | 34,064 | 38,303 | 35,627 | 28,651 |
| Operating Income | -36,085 | -34,064 | -38,303 | -35,627 | -28,651 |
| Other Income | 43 | 15 | 99 | 215 | 638 |
| Pre-tax Income | -36,042 | -34,049 | -38,204 | -35,412 | -28,013 |
| Net Income Continuous | -36,042 | -34,049 | -38,204 | -35,412 | -28,013 |
| Net Income | $-36,042 | $-34,049 | $-38,204 | $-35,412 | $-28,013 |
| EPS Basic Total Ops | -0.76 | -0.70 | -1.01 | -0.94 | -1.15 |
| EPS Basic Continuous Ops | -0.76 | -0.69 | -1.01 | -0.94 | -1.15 |
| EPS Diluted Total Ops | -0.76 | -0.70 | -1.01 | -0.94 | -1.15 |
| EPS Diluted Continuous Ops | -0.76 | -0.69 | -1.01 | -0.94 | -1.15 |
| EBITDA(a) | $-35,371 | $-33,650 | $-38,244 | $-35,741 | $-28,816 |